336.40CHF-4.00%Mkt Cap: 4.42B CHFP/E: 20.65Last update: 2026-06-01
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The com…
Industry Peers
Medical Instruments & Supplies146.01BUSDP/E 50.0
86.09BDKKP/E 40.9
79.36BEURP/E 34.8
40.39BUSDP/E 25.6
30.12BUSDP/E 31.2
27.29BUSDP/E 18.1
25.22BCHFP/E 39.2
22.10BUSDP/E 41.8
Indicators:|
Key Statistics
Company
Market Cap4.42B CHF
Enterprise Value4.84B CHF
Revenue (TTM)730.98M CHF
Gross Profit314.61M CHF
Net Income (TTM)221.93M CHF
Revenue/Share53.72 CHF
Last Price336.40 CHF
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees2.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0019396990
Valuation
P/E (Trailing)20.65
P/E (Forward)23.00
PEG4.22
EV/EBITDA14.85
EV/Revenue6.62
P/S6.30
P/B5.92
EPS (TTM)16.29
EPS (Forward)15.24
52W Range
260.5042% of range441.50
52W High441.50 CHF
52W Low260.50 CHF
Profitability
Gross Margin43.04%
Oper. Margin26.45%
EBITDA Margin44.57%
Profit Margin30.36%
ROE29.66%
ROA16.48%
Growth
Revenue Growth-13.30%
Earnings Growth51.70%
Cash Flow & Leverage
Operating CF306.76M CHF
CapEx (TTM)323.10M CHF
FCF Margin-7.83%
FCF Yield-1.29%
Net Debt232.21M CHF
Net Debt/EBITDA0.71
Balance Sheet
Debt/Equity0.35
Current Ratio1.07
Quick Ratio0.73
Book Value/Sh59.15 CHF
Cash/Share2.172 CHF
Dividends
Fwd Div Rate2.200 CHF
Trail. Div Rate4.400 CHF
Div. Yield0.63%
5Y Avg Yield0.54%
Payout Ratio13.50%
Ex-Div DateJul 4, 2025
Pay DateJul 3, 2024
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)387.83 CHF
Target Range280.00 CHF – 440.00 CHF
# Analysts12
Ownership
Shares Out.13.15M
Float3.51M
Insiders71.80%
Institutions16.03%
Technical
SMA 50294.82 (+14.1%)
SMA 200321.57 (+4.6%)
Beta0.74
S&P 52W Chg27.70%
Avg Vol (30d)23.64K
Avg Vol (10d)29.53K
Technical Indicators
RSI (14)74.5
MACD16.1049
MACD Signal11.0034
MACD Hist.+5.1015
BB Upper361.06 CHF
BB Middle307.93 CHF
BB Lower254.80 CHF
BB Width34.51%
ATR (14)13.53 CHF
Vol Ratio (20d)0.95x